Peer-reviewed medical research, published by the New England Journal of Medicine and the JAMA Network, will be accessible ...

The creation of JAMA+ Trials, a new online platform attesting to the vision, innovation, and resilience represented by clinical trial research is discussed in an editorial. On this platform, readers ...

The AI scribe company said information from the New England Journal of Medicine and the JAMA Network will allow providers to more easily access the latest medical research.

Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, ...

The April issue of Applied Clinical Trials delves into the priorities driving patient engagement approaches today from the technology, regulatory, and site operations fronts. Most protocol deviations ...

This randomized, double-blind, placebo-controlled, single ascending-dose study evaluated oral doses of the botanical kratom ...

Celltrion announced on April 2 that a paper detailing the results of a post-hoc analysis from the global Phase 3 clinical trial of 'Zympendra' (the ...

Cancer treatment often involves significant toxicity and interruptions to daily life. As a result, patient-reported outcomes (PROs) such as health-related quality of life (HRQoL) are an essential ...